Journal of the American Academy of Dermatology
-
Publication Venue For
-
Allergic reactions to tattoos: Retrospective analysis of North American Contact Dermatitis Group data, 2001-2016..
82:e61-e62.
2020
-
Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study..
82:412-419.
2020
-
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin..
81:970-976.
2019
-
Focal atrichia: A diagnostic clue in female pattern hair loss..
80:1538-1543.e1.
2019
-
Early-stage melanoma and hematopoietic stem cell transplantation outcomes..
80:786-788.
2019
-
Systemic timolol exposure following topical application to infantile hemangiomas.
2019
-
Late growth of infantile hemangiomas in children >3 years of age: A retrospective study..
80:493-499.
2019
-
Objective outcome measures: Collecting meaningful data on alopecia areata..
79:470-478.e3.
2018
-
The burden of inbox-messaging systems and its effect on work-life balance in dermatology..
79:361-363.e1.
2018
-
Skin cancer in the military: A systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel..
78:1185-1192.
2018
-
Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.
2018
-
Fontana-Masson stain in fungal infections..
77:1119-1125.
2017
-
SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss..
75:1268-1270.
2016
-
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study..
75:940-949.
2016
-
Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study..
75:639-642.
2016
-
Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome..
75:595-602.
2016
-
The state and consequences of dermatology drug prices in the United States..
75:603-605.
2016
-
Coagulation disorders and their cutaneous presentations: Diagnostic work-up and treatment..
74:795-804.
2016
-
Coagulation disorders and their cutaneous presentations: Pathophysiology..
74:783-792.
2016
-
Wound healing and treating wounds: Chronic wound care and management..
74:607-625.
2016
-
Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium..
74:27-58.
2016
-
The Skin Cancer Objective Structured Clinical Examination (SCOSCE): A multi-institutional collaboration to develop and validate a clinical skills assessment for melanoma..
73:959-965.
2015
-
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts..
72:168-174.
2015
-
Aquagenic wrinkling: a unique facial presentation..
71:e150-e152.
2014
-
Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract..
71:229-236.
2014
-
The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population..
69:214-220.
2013
-
Red fingers syndrome in a patient with pseudolymphoma..
68:e193-e194.
2013
-
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University..
68:749-755.
2013
-
Compassionate care: enhancing physician-patient communication and education in dermatology: Part I: Patient-centered communication..
68:353.e1-353.e8.
2013
-
Compassionate care: enhancing physician-patient communication and education in dermatology: Part II: Patient education..
68:364.e1-364.10.
2013
-
Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma..
67:e198-e199.
2012
-
Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0..
67:1025-1039.
2012
-
Clinicopathologic study of 85 cases of melanoma of the female genitalia..
67:598-605.
2012
-
Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo..
67:379-386.
2012
-
Fibroblastic rheumatism: a report of 4 cases with potential therapeutic implications..
66:959-965.
2012
-
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts..
66:479-485.
2012
-
A systematic review of morphea treatments and therapeutic algorithm..
65:925-941.
2011
-
Use of Apligraf for a devascularized ulcer secondary to mastectomy and radiation..
65:e132-e134.
2011
-
Central hair loss in African American women: incidence and potential risk factors..
64:245-252.
2011
-
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)..
64:352-404.
2011
-
Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups..
63:991-999.
2010
-
Varenicline-induced drug eruption with resulting palmar/plantar hyperhidrosis and dysesthesia..
63:e5-e7.
2010
-
Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole..
62:31-37.
2010
-
Intertriginous pustular psoriasis..
60:679-683.
2009
-
Treatment of juvenile pityriasis rubra pilaris with etanercept..
59:S113-S114.
2008
-
A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation..
59:418-425.
2008
-
Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome: a dermatologist's diagnostic dilemma..
59:S53-S54.
2008
-
Kikuchi's disease: case report and systematic review of cutaneous and histopathologic presentations..
59:130-136.
2008
-
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus..
58:1043-1046.
2008
-
Keratosis follicularis spinulosa decalvans in a family..
58:499-502.
2008
-
Subcutaneous efalizumab is not effective in the treatment of alopecia areata..
58:395-402.
2008
-
Intense pruritus and failure to thrive in Alagille syndrome..
58:S9-11.
2008
-
Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings..
58:185-206.
2008
-
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men..
57:767-774.
2007
-
Lipedema, a frequently unrecognized problem..
57:S1-S3.
2007
-
Scurvy with manifestations limited to a previously injured extremity..
57:S48-S49.
2007
-
Self-healing juvenile cutaneous mucinosis: cases highlighting subcutaneous/fascial involvement..
55:1036-1043.
2006
-
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride..
55:1014-1023.
2006
-
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides..
55:807-813.
2006
-
Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens..
55:642-646.
2006
-
Incontinentia pigmenti in a boy with XXY mosaicism detected by fluorescence in situ hybridization..
55:136-138.
2006
-
Iron deficiency and hair loss: the jury is still out..
54:903-906.
2006
-
Defining early mycosis fungoides..
53:1053-1063.
2005
-
Short anagen syndrome..
53:S130-S134.
2005
-
Evaluation and treatment of male and female pattern hair loss..
52:301-311.
2005
-
Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation..
51:440-447.
2004
-
Beta-lactam antibiotic-induced pseudoporphyria..
51:S80-S82.
2004
-
Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy..
51:98-102.
2004
-
Late-onset melanopenic hypomelanosis as a complication of cosmetic eyeliner tattoo..
69:e144-e146.
2013
-
Melanoma-associated retinopathy: a presenting sign of metastatic disease..
65:e9-11.
2011